[1]
“Toxicities Associated With Dose-Adjusted Epoch-R Compared With R-Chop as Frontline Therapy for Diffuse Large B-Cell Lymphoma: A Study Conducted in a Tertiary Level Hospital of Bangladesh”, Bangla J Med, vol. 33, no. 2, pp. 161–167, Apr. 2022, doi: 10.3329/bjm.v33i2.59289.